Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.88 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.44 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | GALR3 | O60755 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.35 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL28586247 | 1.00 | TSHR (0.88) | TSHRHCAR2FFAR3LCKFYN | |
| Acetic Acid SCHEMBL28160735 | 0.94 | TSHR (0.78) | TSHRHCAR2FFAR3LCKFYN | |
| Bicarbonate SCHEMBL11023772 | 0.94 | TSHR (0.88) | TSHRHCAR2FFAR3LCKFYN | |
| SCHEMBL19193 | 0.94 | — | — | |
| SCHEMBL21064874 | 0.94 | TSHR (1.00) | TSHRHCAR2CHRM2CHRM4CHRM1 | |
| Benzene SCHEMBL8104016 | 0.91 | TSHR (0.82) | TSHRHCAR2CHRM2CHRM4CHRM1 | |
| Methyl Alcohol SCHEMBL584909 | 0.90 | — | — | |
| SCHEMBL3495565 | 0.90 | — | — | |
| Ammonia Solution, Strong SCHEMBL5086843 | 0.90 | — | — | |
| Hydrochloric Acid SCHEMBL2107550 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115109109-B | Synthesis process and application of acetaminophen | 天津大学 | 2023-09-05 | — | — | CN | claimed |
| CN-115109109-A | Synthesis process and application of acetamido abamectin | 天津大学 | 2022-09-27 | — | — | CN | claimed |
| CN-114886853-A | Solid dispersions of ErbB2(HER2) inhibitors | 阵列生物制药公司 | 2022-08-12 | — | — | CN | claimed |
| EP-4337470-A1 | INKJET INK COMPOSITIONS | Videojet Technologies, Inc. (US) | 2024-03-20 | — | — | EP | disclosed |
| US-20240076511-A1 | INKJET INK COMPOSITIONS | VIDEOJET TECHNOLOGIES INC (US) | 2024-03-07 | — | — | US | disclosed |
| CN-117642294-A | Inkjet ink composition | 录象射流技术公司 | 2024-03-01 | — | — | CN | disclosed |
| EP-4252855-A2 | COMPOUNDS FOR USE IN THE TREATMENT OF BRAIN METASTASES IN A PATIENT WITH ERBB2+ BREAST CANCER | Array Biopharma, Inc. (US) | 2023-10-04 | — | — | EP | disclosed |
| CN-115109109-B | Synthesis process and application of acetaminophen | 天津大学 | 2023-09-05 | — | — | CN | disclosed |
| CN-115109109-B | Synthesis process and application of acetaminophen | 天津大学 | 2023-09-05 | — | — | CN | disclosed |
| US-20230271947-A1 | SALT AND CRYSTAL FORM OF KETOHEXOKINASE INHIBITOR AND USE THEREOF | Xuanzhu Biopharmaceutical Co., Ltd. (CN) | 2023-08-31 | — | — | US | disclosed |
| US-20230241066-A1 | POLYMORPHS OF ARRY-380, A SELECTIVE HER2 INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ARRAY BIOPHARMA INC. (US) | 2023-08-03 | — | — | US | disclosed |
| EP-0944572-A1 | PRODUCTION OF ORGANIC CARBOXYLIC ACID ESTERS | Sasol Technology (Proprietary) Limited (ZA) | 1999-09-29 | — | — | EP | disclosed |
| WO-1998025876-A1 | PRODUCTION OF ORGANIC CARBOXYLIC ACID ESTERS | SASOL TECHNOLOGY (PROPRIETARY) LIMITED (ZA) | 1998-06-18 | — | — | WO | disclosed |
| US-4611028-A | ACRYLIC COPOLYMERS | FORD MOTOR COMPANY (US) | 1986-09-09 | — | — | US | disclosed |
| EP-0051400-B1 | POLYMERIC STABILIZER, STABLE DISPERSIONS PREPARED THEREFROM AND PAINT COMPOSITIONS COMPRISING SUCH DISPERSIONS | FORD MOTOR COMPANY LIMITED (GB) | 1986-03-12 | — | — | EP | disclosed |
| US-4504415-A | Synthesis of thymosin α1 and desacetyl thymosin α1 | HOFFMAN-LA ROCHE INC. (US) | 1985-03-12 | — | — | US | disclosed |
| US-4425450-A | LOW SOLVENT CONTENT | FORD MOTOR COMPANY (US) | 1984-01-10 | — | — | US | disclosed |
| US-4415681-A | ACRYLIC RESINS AND BUTYLATED MELAMINE-FORMALDEHYDE RESIN STABILIZER; AUTOMOBILE PAINTS | FORD MOTOR COMPANY (US) | 1983-11-15 | — | — | US | disclosed |
| US-4415697-A | ACRYLIC THERMOSETTING RESINS; AUTOMOBILES; VARNISHES; METALLIZED COATINGS; LACQUERS | FORD MOTOR COMPANY (US) | 1983-11-15 | — | — | US | disclosed |
| EP-0051400-A2 | Polymeric stabilizer, stable dispersions prepared therefrom and paint compositions comprising such dispersions | FORD MOTOR COMPANY LIMITED (GB) | 1982-05-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230271947-A1 | SALT AND CRYSTAL FORM OF KETOHEXOKINASE INHIBITOR AND USE THEREOF | KHK, HK1, HKDC1 | TSHR 3782/4885HCAR2 1187/4885FFAR3 978/4885 |
| US-20230241066-A1 | POLYMORPHS OF ARRY-380, A SELECTIVE HER2 INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ERBB2, ERBB3, ERBB4 | TSHR 875/4885HCAR2 3239/4885FFAR3 1514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.